Miliary Tuberculosis in a Crohn’s Disease Patient: The Risk beyond the Screening

Miliary Tuberculosis in a Crohn’s Disease Patient: The Risk beyond the Screening

Tumor necrosis factor alpha (TNFα) antagonist is recognized as an effective treatment to achieve clinical remission and healing mucosal in patients with moderate to severe active Crohn’s disease. Considering that it plays a central role in immune-mediated modulation, there are some obvious concerns...

Full description

Bibliographic Details
Main Authors: Liliana Pereira Carvalho, Maria Ana Túlio, José Pedro Rodrigues, Tiago Bana e Costa, Cristina Chagas
Format: Article
Language:English
Published: Karger Publishers 2018-03-01
Series:GE: Portuguese Journal of Gastroenterology
Subjects:
Crohn’s disease
Anti-TNFα therapy
Interferon-γ release assays
Miliary tuberculosis
Online Access:https://www.karger.com/Article/FullText/487297

Similar Items

Similar Items